XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.13

-0.5%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (6483)	6/17/1998 10:10:00 AM
From: aknahow	Read Replies (3) of 17367

Bob, what is the date of the BPI/E5 study you posted? BTW Bayer is reported looking for a large merger partner. Others mention duPont, Astra or Zeneca as possible targets. Another article on Merck, which has said it is not seeking any major acquisitions, as a potential merger candidate itself. Merck is looking, according to the article, for drugs developed by others which it could sell. Obviously, IMO MRK would be great marketing partner for XOMA. Don't know what XOMA & MRK think about this. <g> Where is Dr. Ricca? He probably has done so well with both PFE and MRK that he could now buy a lot more XOMA.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next